Can Offspring support us into the Clinical Phase?

Yes, our support is designed to span the preclinical to clinical transition. For the clinical phase, we specialize in providing crucial exploratory clinical endpoints and developing effective patient stratification biomarker strategies.

Furthermore, through our strategic partnership with Flagship Biosciences, we provide a seamless bridge to CAP/CLIA-certified environments. This ensures that the exploratory assays and biomarker signatures we develop with you during the preclinical phase can be smoothly validated and deployed for regulated clinical trial sample analysis, saving you critical time and resources.

This integrated support makes us an ideal collaborative preclinical research partner, offering you a single, continuous scientific relationship from first tissue screen to first-in-human trials.